Kymera Therapeutics, Inc. Annual Depreciation in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Kymera Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2023.
  • Kymera Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $2M, a 122% increase year-over-year.
  • Kymera Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $6.3M, a 80% increase year-over-year.
  • Kymera Therapeutics, Inc. annual Depreciation for 2023 was $3.6M, a 20% increase from 2022.
  • Kymera Therapeutics, Inc. annual Depreciation for 2022 was $3M, a 25% increase from 2021.
  • Kymera Therapeutics, Inc. annual Depreciation for 2021 was $2.4M, a 33.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.6M +$600K +20% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $3M +$600K +25% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $2.4M +$600K +33.3% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $1.8M +$1M +125% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $800K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.